Stroke Prevention and Rhythm Interventions in Atrial Fibrillation "SPRINT-AF"


Phase N/A Results N/A

Eligibility Criteria

Inclusion Criteria

- Documented atrial fibrillation (ECG, rhythm strip, device interrogation, discussion of an AF diagnosis in the participant's clinical report) within the past 10 years; paroxysmal, persistent or permanent
- Age > 18 years
- Most recent visit for a patient having had a clinical visit with Investigator occurring within the past one year

Exclusion Criteria

- Valvular AF (hemodynamically significant valvular heart disease including rheumatic mitral valve disease or at least moderate aortic valve stenosis)
- Life expectancy < 12 months
- Active malignancy (treated or untreated)
- Indication for systemic anticoagulation independent of atrial fibrillation (venous thromboembolism, mechanical heart valve)
- Prior participation in any OAC randomized clinical trial